SPONSOR
Institut Bergonié
Total Trials
2
Recruiting
2
Phases
Phase 2
Institut Bergonié is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Prostate Cancer, Sarcoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Bergonié
How many clinical trials has Institut Bergonié sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Institut Bergonié, of which 2 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Sarcoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Bergonié research focus on?
Institut Bergonié clinical trials span Prostate Cancer, Sarcoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Bergonié clinical trial?
To participate in a Institut Bergonié trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Bergonié trials with current recruitment status updated daily.
Clinical Trials by Institut Bergonié
NCT05346848 Phase 2
Recruiting
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Prostate Cancer
NCT03978039
Recruiting
National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group
Sarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology